These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 18640164)
21. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes. Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012 [TBL] [Abstract][Full Text] [Related]
22. Combining an EGF-based cancer vaccine with chemotherapy in advanced nonsmall cell lung cancer. Neninger E; Verdecia BG; Crombet T; Viada C; Pereda S; Leonard I; Mazorra Z; Fleites G; González M; Wilkinson B; González G; Lage A J Immunother; 2009 Jan; 32(1):92-9. PubMed ID: 19307998 [TBL] [Abstract][Full Text] [Related]
23. Assessment of vaccine potential of the Neisseria-specific protein NMB0938. Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688 [TBL] [Abstract][Full Text] [Related]
24. Neonatal vaccination with Mycobacterium bovis BCG: potential effects as a priming agent shown in a heterologous prime-boost immunization protocol. Rahman MJ; Fernández C Vaccine; 2009 Jun; 27(30):4038-46. PubMed ID: 19379788 [TBL] [Abstract][Full Text] [Related]
25. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations. Berner VK; Sura ME; Hunter KW Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470 [TBL] [Abstract][Full Text] [Related]
26. Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720. Lawrence GW; Saul A; Giddy AJ; Kemp R; Pye D Vaccine; 1997 Feb; 15(2):176-8. PubMed ID: 9066035 [TBL] [Abstract][Full Text] [Related]
27. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity. de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296 [TBL] [Abstract][Full Text] [Related]
28. [Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice]. Cao Y; Zhang DM; Pan WQ Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Oct; 26(5):327-31. PubMed ID: 19157293 [TBL] [Abstract][Full Text] [Related]
29. Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants. Morera Y; Bequet-Romero M; Ayala M; Lamdán H; Agger EM; Andersen P; Gavilondo JV Angiogenesis; 2008; 11(4):381-93. PubMed ID: 19034678 [TBL] [Abstract][Full Text] [Related]
31. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine. Huang Y; Cyr SL; Burt DS; Anderson R J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722 [TBL] [Abstract][Full Text] [Related]
32. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections. Hickey DK; Aldwell FE; Beagley KW Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810 [TBL] [Abstract][Full Text] [Related]
33. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models. Dharmapuri S; Aurisicchio L; Neuner P; Verdirame M; Ciliberto G; La Monica N Cancer Gene Ther; 2009 May; 16(5):462-72. PubMed ID: 18989354 [TBL] [Abstract][Full Text] [Related]
34. Influence of carrier proteins on the immunologic response to haptenic antitetrodotoxin vaccine. Xu QH; Zhao XN; Cheng JP; Wei CH; Zhang QH; Rong KT Bioconjug Chem; 2006; 17(6):1508-13. PubMed ID: 17105230 [TBL] [Abstract][Full Text] [Related]
35. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model. Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492 [TBL] [Abstract][Full Text] [Related]
36. Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review. van Doorn E; Liu H; Huckriede A; Hak E Hum Vaccin Immunother; 2016; 12(1):159-69. PubMed ID: 26378866 [TBL] [Abstract][Full Text] [Related]
37. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice. Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115 [TBL] [Abstract][Full Text] [Related]
38. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445 [TBL] [Abstract][Full Text] [Related]
39. Induction of a protective immune response against swine Chlamydophila abortus infection in mice following co-vaccination of omp-1 DNA with recombinant MOMP. Zhang F; Li S; Yang J; Yang L; He C Zoonoses Public Health; 2009 Mar; 56(2):71-6. PubMed ID: 18721226 [TBL] [Abstract][Full Text] [Related]
40. Homologous prime-boost strategy in neonate mice using Neisseria lactamica. Ito AY; Néri S; Machado MS; Tunes CF; De Gaspari EN Vaccine; 2009 May; 27(25-26):3422-8. PubMed ID: 19460600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]